BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 11836403)

  • 21. Cyclophilin A-independent replication of a human immunodeficiency virus type 1 isolate carrying a small portion of the simian immunodeficiency virus SIV(MAC) gag capsid region.
    Fujita M; Yoshida A; Miyaura M; Sakurai A; Akari H; Koyama AH; Adachi A
    J Virol; 2001 Nov; 75(21):10527-31. PubMed ID: 11581426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.
    Kulkosky J; BouHamdan M; Geist A; Pomerantz RJ
    Virology; 1999 Mar; 255(1):77-85. PubMed ID: 10049823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 Gag Recruits Oligomeric Vpr via Two Binding Sites in p6, but Both Mature p6 and Vpr Are Rapidly Lost upon Target Cell Entry.
    Wanaguru M; Bishop KN
    J Virol; 2021 Aug; 95(17):e0055421. PubMed ID: 34106747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
    Kondo E; Mammano F; Cohen EA; Göttlinger HG
    J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811.
    Dorfman T; Göttlinger HG
    J Virol; 1996 Sep; 70(9):5751-7. PubMed ID: 8709190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization.
    Colgan J; Yuan HE; Franke EK; Luban J
    J Virol; 1996 Jul; 70(7):4299-310. PubMed ID: 8676452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in CypA Binding Region of HIV-1 Capsid Affect Capsid Stability and Viral Replication in Primary Macrophages.
    Setiawan LC; van Dort KA; Rits MA; Kootstra NA
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):390-8. PubMed ID: 26414211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
    Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
    EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.
    Paxton W; Connor RI; Landau NR
    J Virol; 1993 Dec; 67(12):7229-37. PubMed ID: 8230445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions.
    Dorfman T; Weimann A; Borsetti A; Walsh CT; Göttlinger HG
    J Virol; 1997 Sep; 71(9):7110-3. PubMed ID: 9261445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein.
    Braaten D; Ansari H; Luban J
    J Virol; 1997 Mar; 71(3):2107-13. PubMed ID: 9032343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA.
    De Iaco A; Luban J
    Retrovirology; 2014 Jan; 11():11. PubMed ID: 24479545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 p6-Another viral interaction partner to the host cellular protein cyclophilin A.
    Solbak SM; Reksten TR; Röder R; Wray V; Horvli O; Raae AJ; Henklein P; Henklein P; Fossen T
    Biochim Biophys Acta; 2012 Apr; 1824(4):667-78. PubMed ID: 22342556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells.
    Braaten D; Luban J
    EMBO J; 2001 Mar; 20(6):1300-9. PubMed ID: 11250896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses.
    Schaller T; Ylinen LM; Webb BL; Singh S; Towers GJ
    J Virol; 2007 Sep; 81(18):10055-63. PubMed ID: 17609268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catalysis and binding of cyclophilin A with different HIV-1 capsid constructs.
    Bosco DA; Kern D
    Biochemistry; 2004 May; 43(20):6110-9. PubMed ID: 15147195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A.
    Ackerson B; Rey O; Canon J; Krogstad P
    J Virol; 1998 Jan; 72(1):303-8. PubMed ID: 9420228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SUN1 Regulates HIV-1 Nuclear Import in a Manner Dependent on the Interaction between the Viral Capsid and Cellular Cyclophilin A.
    Luo X; Yang W; Gao G
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells.
    Berthoux L; Sebastian S; Sokolskaja E; Luban J
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14849-53. PubMed ID: 16203999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
    Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
    Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.